Acadia Healthcare (NASDAQ:ACHC) Announces Earnings Results, Beats Expectations By $0.03 EPS

Acadia Healthcare (NASDAQ:ACHC) released its earnings results on Tuesday. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03, Zacks reports. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. Acadia Healthcare updated its FY 2026 guidance to 1.450-1.600 EPS.

Acadia Healthcare Stock Performance

Shares of ACHC traded up $0.19 during mid-day trading on Tuesday, reaching $32.69. The company had a trading volume of 4,345,024 shares, compared to its average volume of 3,342,620. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $35.83. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The stock has a market capitalization of $3.01 billion, a P/E ratio of -2.67, a PEG ratio of 11.51 and a beta of 0.64. The stock has a 50 day moving average of $27.78 and a two-hundred day moving average of $23.36.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Inspire Investing LLC lifted its stake in shares of Acadia Healthcare by 77.9% in the 4th quarter. Inspire Investing LLC now owns 32,664 shares of the company’s stock valued at $464,000 after purchasing an additional 14,306 shares during the period. Bayesian Capital Management LP acquired a new stake in Acadia Healthcare during the second quarter valued at $460,000. Corient Private Wealth LLC increased its holdings in Acadia Healthcare by 55.6% in the second quarter. Corient Private Wealth LLC now owns 19,056 shares of the company’s stock valued at $432,000 after buying an additional 6,813 shares in the last quarter. Vident Advisory LLC acquired a new position in shares of Acadia Healthcare in the third quarter worth about $418,000. Finally, Brevan Howard Capital Management LP purchased a new stake in shares of Acadia Healthcare during the 3rd quarter worth about $392,000.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on ACHC shares. Guggenheim boosted their price objective on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. KeyCorp boosted their price target on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. UBS Group raised their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Finally, TD Cowen upped their target price on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $28.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.